Detalhe da pesquisa
1.
Knockout of interleukin-17A diminishes ventricular arrhythmia susceptibility in diabetic mice via inhibiting NF-κB-mediated electrical remodeling.
Acta Pharmacol Sin
; 43(2): 307-315, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911193
2.
Interleukin-17 upregulation participates in the pathogenesis of heart failure in mice via NF-κB-dependent suppression of SERCA2a and Cav1.2 expression.
Acta Pharmacol Sin
; 42(11): 1780-1789, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589793
3.
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice.
J Mol Cell Cardiol
; 115: 64-72, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305939
4.
Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice.
J Cardiovasc Electrophysiol
; 29(10): 1436-1443, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016000
5.
Increment of late sodium currents in the left atrial myocytes and its potential contribution to increased susceptibility of atrial fibrillation in castrated male mice.
Heart Rhythm
; 14(7): 1073-1080, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185917
6.
Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFß1 and miR-29 pathways.
Sci Rep
; 6: 23010, 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26972749